Comparing Differences in Executive Functions of Patients with Bipolar Disorder, Patients with Major Depressive Disorder, and the Control Group and Its Relationship with Their Clinical Characteristics

Malekizadeh, Hossein; Ahmadi, Davoud; Mesbahi, Mehdi; Saed, Omid

Volume 13 - Articles-1402 MEJDS (2023) 13: 123 | Back to browse issues page

Research code: A-10-924-16

Ethics code: IR.ZUMS.REC.1399.054

Mendeley

Zotero

RefWorks

Malekizadeh H, Ahmadi D, Mesbahi M, Saed O. Comparing Differences in Executive Functions of Patients with Bipolar Disorder, Patients with Major Depressive Disorder, and the Control Group and Its Relationship with Their Clinical Characteristics. MEJDS 2023; 13 :123-123
URL: http://jdisabilstud.org/article-1-2863-en.html

Comparing Differences in Executive Functions of Patients with Bipolar Disorder, Patients with Major Depressive Disorder, and the Control Group and Its Relationship with Their Clinical Characteristics

Hossein Malekizadeh¹

, Davoud Ahmadi¹

, Mehdi Mesbahi²

, Omid Saed ^*³

1- MA in Clinical Psychology, Department of Clinical Psychology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2- PhD Student in Psychology, Department of Psychology, Faculty of Literature and Humanities, Khorramabad University, Lorestan, Iran
3- Assistant Professor, Department of Clinical Psychology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Abstract: (873 Views)

Abstract
Background & Objectives: Neurocognitive disorder is one of the most important symptoms of mood disorders. Previous studies have shown that executive function is significantly impaired during acute periods of depression in bipolar and major depressive disorders. On the other hand, some studies have shown that executive functions in bipolar patients who have not received psychotropic medication in recent weeks or months are not significantly different from healthy individuals. Therefore, studies on the characteristics of executive functions in patients with mood disorders have yielded contradictory results. One of the causes of contradiction is overlooking the effects of psychotropic medication and the clinical characteristics of patients as influential factors in their executive functions. Therefore, this study aims to compare the differences in executive functions of patients with major depressive disorder and bipolar patients in the depressive phase (both groups without a history of drug use) and its relationship with their clinical features.
Methods: The study method was causal–comparative. For the patient group, the statistical population included all major depressed and bipolar patients referred to the Sohrevardi Clinic in Zanjan City, Iran, in 2021. For the control group, the statistical population consisted of normal people who lived in Zanjan in 2021. The study sample consisted of 90 people (30 depressed patients, 30 bipolar patients, and 30 normal people). They were selected by the available sampling method based on the inclusion and exclusion criteria. Demographic and clinical information of patients were collected with self–report forms. This information included age, gender, education, number of periods of mood disorder, mania/hypomania periods, depressive mood periods, total duration of the disorder, and duration of the current depressive period. Also, all samples were assessed by Structured Clinical Interview for DSM–5 (First et al., 2016), Beck Depression Inventory–II (Beck et al., 1996), Young Mania Rating Scale (Young et al., 1978), The Stroop color–word test (Stroop, 1935), and the Wisconsin card sorting test (Berg, 1948). The Kruskal–Wallis test was performed to compare the differences in age and education between the three groups. The clinical data were compared using the Mann–Whitney U test. Group differences in Stroop Color–Word Test and Wisconsin Card Sorting Test indices were tested by analysis of covariance (ANCOVA), with age and education years as covariates while groups and gender were fixed factors. Least Significant Difference (LSD) was used as the post hoc multiple comparisons to identify the differences between groups. The correlations between executive function and clinical variables were identified using partial correlation analysis. Statistical analyses were performed in SPSS software version 23 at a significance level of 0.05.
Results: In bipolar patients, only the number of missing in the Stroop Color–Word Test was more than the control group (p=0.047). In the group of depressed patients in the Stroop Color–Word Test, the number of correct items was lower, and the number of missing was higher than in the control group (p=0.017) and more missed answers (p=0.005) in comparison control group. Also, the group of depressed patients in the Wisconsin Test showed more total number of answers (p=0.032), more percentage of errors (p=0.045), less percentage of conceptual answers (p=0.015), less number of completed classes (p=0.014) and more failure to maintain classes (p=0.037) compared to the control group. Depressed patients had a poorer performance in the percentage of errors (p=0.039) and percentage of conceptual answers (p=0.040) in the Wisconsin test compared to bipolar patients. In bipolar patients, no correlation was found between the indices of Stroop and Wisconsin tests and the clinical characteristics of the patients (p>0.05). In depressed patients, the number of episodes of mood disorder has a significant correlation with the percentage of errors (p=0.002), the percentage of continuous answers (p=0.001), the percentage of conceptual answers (p=0.002), and the number of completed classes (p=0.007) in the Wisconsin Test.
Conclusion: According to the findings, executive functions in depressed patients are weaker than in bipolar patients. Although the executive functions in depressed patients are weaker than the control group, the performance of bipolar patients is comparable to the control group. The executive functions of bipolar patients are probably related to the length of the current depressive episode. In comparison, depressed patients are affected by the number of past mood episodes.

Keywords: Bipolar disorder, Major depressive disorder, Executive functions

Full-Text [PDF 735 kb] (230 Downloads)

Type of Study: Original Research Article | Subject: Psychology

References

1. Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, et al. Bipolar disorders. Nat Rev Dis Primers. 2018;4:18008. [DOI]

2. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M, et al. Lifetime and 12–month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry. 2007;64(5):543–52. [DOI]

3. Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1211–59. [DOI]

4. Smith DJ, Griffiths E, Kelly M, Hood K, Craddock N, Simpson SA. Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatry. 2011;199(1):49–56. [DOI]

5. Xiang YT, Zhang L, Wang G, Hu C, Ungvari GS, Dickerson FB, et al. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China. Bipolar Disord. 2013;15(2):199–205. [DOI]

6. Hughes T, Cardno A, West R, Marino–Francis F, Featherstone I, Rolling K, et al. Unrecognised bipolar disorder among UK primary care patients prescribed antidepressants: an observational study. Br J Gen Pract. 2016;66(643):e71-77. [DOI]

7. Bonnín CM, Torrent C, Goikolea JM, Reinares M, Solé B, Valentí M, et al. The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2014;264(3):247–54. [DOI]

8. Woo YS, Rosenblat JD, Kakar R, Bahk WM, McIntyre RS. Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clin Psychopharmacol Neurosci. 2016;14(1):1–16. [DOI]

9. Xu G, Lin K, Rao D, Dang Y, Ouyang H, Guo Y, et al. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. J Affect Disord. 2012;136(3):328–39. [DOI]

10. Banich MT. Executive function: the search for an integrated account. Curr Dir Psychol Sci. 2009;18(2):89–94. [DOI]

11. Snyder HR. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta–analysis and review. Psychol Bull. 2013;139(1):81–132. [DOI]

12. Cai Y, Kuang W, Guo T, Yan L, Zhu J, Chen H. Clinical characteristics and cognitive function of unipolar and bipolar depression. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37(11):1152–5. [Chinese] [DOI]

13. Daniel BD, Montali A, Gerra ML, Innamorati M, Girardi P, Pompili M, et al. Cognitive impairment and its associations with the path of illness in affective disorders: a comparison between patients with bipolar and unipolar depression in remission. J Psychiatr Pract. 2013;19(4):275–87. [DOI]

14. Keefe RSE, McClintock SM, Roth RM, Doraiswamy PM, Tiger S, Madhoo M. Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75(8):864–76. [DOI]

15. Penfold C, Vizueta N, Townsend JD, Bookheimer SY, Altshuler LL. Frontal lobe hypoactivation in medication–free adults with bipolar II depression during response inhibition. Psychiatry Res. 2015;231(3):202–9. [DOI]

16. Taylor Tavares JV, Clark L, Cannon DM, Erickson K, Drevets WC, Sahakian BJ. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry. 2007;62(8):917–24. [DOI]

17. Hooman HA. Research methodology in behavioral sciences. Tehran: SAMT Pub; 2017, pp:41–322. [Persian]

18. First MB, Williams JBW, Karg RS, Spitzer RL. SCID–5–CV: structured clinical interview for DSM–5 disorders: clinician version. Arlington, VA: American Psychiatric Association Publishing; 2016, pp:12–20.

19. Shabani A, Masoumian S, Zamirinejad S, Hejri M, Pirmorad T, Yaghmaeezadeh H. Psychometric properties of structured clinical interview for DSM–5 disorders–clinician version (SCID–5–CV). Brain Behav. 2021;11(5):e01894. [DOI]

20. Beck AT, Steer RA, Brown G. Beck depression inventory–II [Internet]. 2011 [cited 2023]. Available from: [DOI]

21. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck depression inventory: twenty–five years of evaluation. Clinical Psychology Review. 1988;8(1):77–100. [DOI]

22. Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian–language version of the Beck depression inventory–second edition: BDI–II–PERSIAN. Depress Anxiety. 2005;21(4):185–92. [DOI]

23. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35. [DOI]

24. Rush AJ, First MB, Blacker D, American Psychiatric Association, editors. Handbook of psychiatric measures. 2nd ed. Washington, DC: American Psychiatric Pub; 2008, pp:540–2.

25. Ebrahimi A, Kheyr Z, Nasiri H, Barnamanesh A. Reliability, Validity, Factor and discrimination power analysis of young mania rating scale among unipolar, bipolar depression and healthy people. Jundishapur Scientific Medical Journal. 2017;16(3):333–44. [Persian] [DOI]

26. Mohammadi Z, Pourshahbaz A, Poshtmashhadi M, Dolatshahi B, Barati F, Zarei M. Psychometric properties of the young mania rating scale as a mania severity measure in patients with bipolar I disorder. Practice in Clinical Psychology. 2018;6(3):175–82.

27. Stroop JR. Studies of interference in serial verbal reactions. Journal of Experimental Psychology. 1935;18(6):643–62. [DOI]

28. Periáñez JA, Lubrini G, García-Gutiérrez A, Ríos–Lago M. Construct validity of the stroop color–word test: influence of speed of visual search, verbal fluency, working memory, cognitive flexibility, and conflict monitoring. Arch Clin Neuropsychol. 2021;36(1):99–111. [DOI]

29. Uttl B, Graf P. Color–word Stroop test performance across the adult life span. J Clin Exp Neuropsychol. 1997;19(3):405–20. [DOI]

30. Alboghbeish S, Abedanzadeh R, Shetab Boushehri N, Daneshfar A. The effect of Stroop effect and stimulus onset asynchronies on the psychological refractory period. Journal of Cognitive Psychology. 2017;5(2):51–60. [Persian] [Article]

31. Berg EA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol. 1948;39:15–22. [DOI]

32. Chiu EC, Wu WC, Hung JW, Tseng YH. Validity of the Wisconsin card sorting test in patients with stroke. Disabil Rehabil. 2018;40(16):1967–71. [DOI]

33. Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary, 3rd ed. New York, NY, US: Oxford University Press; 2006, pp:558–63.

34. Shahgholian M, Azadfallah P, Fathi–Ashtiani A, Khodadadi M. Design of the Wisconsin card sorting test (WCST) computerized version: theoretical fundamental, developing and psychometrics characteristics. Clinical Psychology Studies. 2012;1(4):110–34. [Persian] [Article]

35. Epp AM, Dobson KS, Dozois DJA, Frewen PA. A systematic meta–analysis of the Stroop task in depression. Clin Psychol Rev. 2012;32(4):316–28. [DOI]

36. Merriam EP, Thase ME, Haas GL, Keshavan MS, Sweeney JA. Prefrontal cortical dysfunction in depression determined by Wisconsin card sorting test performance. Am J Psychiatry. 1999;156(5):780–2. [DOI]

37. Pliatsikas C, Veríssimo J, Babcock L, Pullman MY, Glei DA, Weinstein M, et al. Working memory in older adults declines with age, but is modulated by sex and education. Q J Exp Psychol (Hove). 2019;72(6):1308–27. [DOI]

38. Grande I, Sanchez-Moreno J, Sole B, Jimenez E, Torrent C, Bonnin CM, et al. High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment. J Affect Disord. 2017;208:621–7. [DOI]

39. Steen NE, Aas M, Simonsen C, Dieset I, Tesli M, Nerhus M, et al. Serum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic setting. Int J Bipolar Disord. 2016;4(1):24. [DOI]

40. Bryan J, Luszcz MA. Measurement of executive function: considerations for detecting adult age differences. J Clin Exp Neuropsychol. 2000;22(1):40–55. [DOI]

41. Martino DJ, Igoa A, Marengo E, Scápola M, Strejilevich SA. Longitudinal relationship between clinical course and neurocognitive impairments in bipolar disorder. J Affect Disord. 2018;225:250–5. [DOI]

42. Fiedorowicz JG, Prossin AR, Johnson CP, Christensen GE, Magnotta VA, Wemmie JA. Peripheral inflammation during abnormal mood states in bipolar I disorder. J Affect Disord. 2015;187:172–8. [DOI]

43. Magioncalda P, Martino M, Conio B, Piaggio N, Teodorescu R, Escelsior A, et al. Patterns of microstructural white matter abnormalities and their impact on cognitive dysfunction in the various phases of type I bipolar disorder. J Affect Disord. 2016;193:39–50. [DOI]

44. McIntyre RS, Woldeyohannes HO, Soczynska JK, Maruschak NA, Wium-Andersen IK, Vinberg M, et al. Anhedonia and cognitive function in adults with MDD: results from the international mood disorders collaborative project. CNS Spectr. 2016;21(5):362–6. [DOI]

45. Haeffel GJ, Gibb BE, Metalsky GI, Alloy LB, Abramson LY, Hankin BL, et al. Measuring cognitive vulnerability to depression: development and validation of the cognitive style questionnaire. Clin Psychol Rev. 2008;28(5):824–36. [DOI]

46. Li CT, Hsieh JC, Wang SJ, Yang BH, Bai YM, Lin WC, et al. Differential relations between fronto–limbic metabolism and executive function in patients with remitted bipolar I and bipolar II disorder. Bipolar Disord. 2012;14(8):831–42. [DOI]